Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115768) titled '18F-MFBG PET/CT in the diagnosis of neuroendocrine tumors expressing hNET: a prospective, diagnostic clinical study' on Dec. 31, 2025.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Peking University Shenzhen Hospital
Condition:
Neuroendocrine tumor
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-01
Target Sample Size: Neuroendocrine Tumor Observation group:186;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=273993
Disclaimer: Curated by HT Syndication....